AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8668962 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of 1 g of IgG in 10 ml saline
Number of subjects: 11
Study 8668962 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection of 10 ml physiological saline
Number of subjects: 11
Study 1844697 — intervention group
Group type: EXPERIMENTAL
Intervention: Two formulations
Number of subjects: 0
Study 1844697 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence interval approach
Number of subjects: 0
Study 1844697 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical data set from a two‐by‐two crossover bioequivalence study
Number of subjects: 0
Study 6303104 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy density diet
Number of subjects: 20
Study 6303104 — intervention group
Group type: COMPARATOR
Intervention: High energy density diet
Number of subjects: 20
Study 30629585 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure checks once a year for chronic disease patients without a diagnosis of hypertension
Number of subjects: 8947
Study 30629585 — intervention group
Group type: EXPERIMENTAL
Intervention: Current practice of blood pressure checks every 7 weeks for individuals with hypertension
Number of subjects: 8947
Study 30629585 — intervention group
Group type: COMPARATOR
Intervention: Routine blood pressure checks at every visit
Number of subjects: 8947
Study 30106172 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab (120 mg subcutaneous injection)
Number of subjects: 187
Study 30106172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 25469889 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuning in to Kids
Number of subjects: 320
Study 25469889 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Parenting Program
Number of subjects: 320
Study 25469889 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 320
Study 24202432 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-ventilation technique
Number of subjects: 42
Study 24202432 — intervention group
Group type: COMPARATOR
Intervention: Non-protocolized anesthesia
Number of subjects: 42
Study 23176889 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous allergy immunotherapy
Number of subjects: 18
Study 19254374 — intervention group
Group type: EXPERIMENTAL
Intervention: Time constraints (median agreement of 3, IQR 2-5)
Number of subjects: 35
Study 19254374 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficulties including identified eligible patients (median agreement of 5, IQR 3-6)
Number of subjects: 35
Study 19254374 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial design barriers, lack of access to treatment, individual barriers of recruiting physicians, insufficient training of recruiting physicians
Number of subjects: 35
Study 17966072 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum (Amphojel plus citrate) administered orally for 3 days followed by a 3-week washout, then matched placebo for 3 days.
Number of subjects: 0
Study 17966072 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered for 3 days after aluminum treatment.
Number of subjects: 0
Study 15564357 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 73
Study 15564357 — intervention group
Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 73
Study 11556665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound time-of-flight (ToF) posturography measurements during balance assessment on solid and soft surfaces.
Number of subjects: 0
Study 11556665 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular therapy post-therapy.
Number of subjects: 0
Study 11556665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound ToF method for tracking sway.
Number of subjects: 0
Study 10074720 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intravenous immunoglobulin (IVIG) therapy, 750-1000 mg/kg for infants <1000 g, 500-750 mg/kg for infants 1001-1500 g, administered every 2 weeks until 1800 g or discharge
Number of subjects: 61
Study 10074720 — intervention group
Group type: COMPARATOR
Intervention: Control group received saline infusion, administered every 2 weeks until 1800 g or discharge
Number of subjects: 61
Study 7839076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone pulse therapy (100 mg in 250 ml 5% dextrose infused over 1 h, repeated every month for 6 months)
Number of subjects: 35
Study 7839076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 7839076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone pulse therapy
Number of subjects: 35
Study 3060542 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% acyclovir cream applied five times daily for 5 days
Number of subjects: 64
Study 3060542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 28854833 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacha inchi flour (30g)
Number of subjects: 30
Study 28854833 — intervention group
Group type: COMPARATOR
Intervention: Soybean flour (30g)
Number of subjects: 30
Study 27478849 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical pirfenidone plus conventional treatment
Number of subjects: 24
Study 27478849 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment only
Number of subjects: 24
Study 24599010 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose angiotensin II receptor blocker (ARB)
Number of subjects: 1164
Study 24599010 — intervention group
Group type: COMPARATOR
Intervention: ARB plus calcium channel blocker (CCB)
Number of subjects: 1164
Study 22893165 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner violence screen plus a list of local partner violence resources (n = 801)
Number of subjects: 2708
Study 22893165 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner violence resource list only (n = 772)
Number of subjects: 2708
Study 22893165 — intervention group
Group type: COMPARATOR
Intervention: No-screen, no-partner violence list control group (n = 791)
Number of subjects: 2708
Study 20674497 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic therapy (coenzyme Q(10), magnesium orotate, lipoic acid, omega‐3 fatty acids and selenium)
Number of subjects: 117
Study 20674497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 17945470 — intervention group
Group type: EXPERIMENTAL
Intervention: Depakine-chrono (40 patients) for 6 weeks
Number of subjects: 80
Study 17945470 — intervention group
Group type: COMPARATOR
Intervention: Placebo (40 patients) for 6 weeks
Number of subjects: 80
Study 15748102 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate Rapid Maxillary Expansions and Constrictions (Alt‐RAMEC)
Number of subjects: 26
Study 15748102 — intervention group
Group type: COMPARATOR
Intervention: Rapid Maxillary Expansion (RME)
Number of subjects: 26
Study 12452233 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of EMLA cream
Number of subjects: 90
Study 12452233 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of 1% lidocaine
Number of subjects: 90
Study 12452233 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of 2% lidocaine
Number of subjects: 90
Study 12452233 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 90
Study 10592355 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly hemodialysis
Number of subjects: 15067
Study 10592355 — intervention group
Group type: COMPARATOR
Intervention: Thrice-weekly hemodialysis
Number of subjects: 15067
Study 7577286 — intervention group
Group type: EXPERIMENTAL
Intervention: Mivacurium 0.2 mg kg‐1
Number of subjects: 75
Study 7577286 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.6 mg kg‐1
Number of subjects: 75
Study 7577286 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubocurarine 0.5 mg kg‐1
Number of subjects: 75
Study 7577286 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium 0.6 mg kg‐1
Number of subjects: 75
Study 7577286 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium 0.1 mg kg‐1
Number of subjects: 75
Study 1962902 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (FR‐860) at 75 U/kg/day in group I (n = 27)
Number of subjects: 56
Study 1962902 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (FR‐860) at 150 U/kg/day in group II (n = 29)
Number of subjects: 56
Study 1962902 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 56
Study 6273027 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3 (mean dose 0.5 microgram daily)
Number of subjects: 17
Study 6273027 — intervention group
Group type: COMPARATOR
Intervention: D3 (dose 100 microgram daily)
Number of subjects: 17
Study 29942978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac shock wave therapy (CSWT)
Number of subjects: 50
Study 27798812 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking training (NWT)
Number of subjects: 20
Study 27798812 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training (TT)
Number of subjects: 20
Study 25599449 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement (5 g of transdermal gel daily for 14 weeks)
Number of subjects: 84
Study 25599449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (14 weeks)
Number of subjects: 84
Study 24073230 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire modes
Number of subjects: 1483
Study 24073230 — intervention group
Group type: COMPARATOR
Intervention: Interviewer-administered questionnaire mode
Number of subjects: 1483
Study 24073230 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered modes (when completed twice)
Number of subjects: 1483
Study 21416219 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibric acid 135 mg added to moderate-dose statin (rosuvastatin 20 mg, simvastatin 40 mg, or atorvastatin 40 mg) for 52 weeks
Number of subjects: 92
Study 21416219 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibric acid with moderate-dose statin
Number of subjects: 92
Study 19531728 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular coffee (caffeinated)
Number of subjects: 103
Study 19531728 — intervention group
Group type: COMPARATOR
Intervention: De-caffeinated coffee
Number of subjects: 103
Study 15641936 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-T3 positive HD-pts (decreased fT3 and increased rT3)
Number of subjects: 52
Study 15641936 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-T3 positive HD-pts
Number of subjects: 52
Study 15641936 — intervention group
Group type: EXPERIMENTAL
Intervention: QRSd
Number of subjects: 52
Study 15641936 — intervention group
Group type: EXPERIMENTAL
Intervention: RMS40
Number of subjects: 52
Study 12747648 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning laser polarimetry (GDx-NFA)
Number of subjects: 53
Study 12747648 — intervention group
Group type: EXPERIMENTAL
Intervention: Confocal scanning laser ophthalmoscopy (HRT-II)
Number of subjects: 53
Study 12747648 — intervention group
Group type: EXPERIMENTAL
Intervention: GDx parameters
Number of subjects: 53
Study 10567757 — intervention group
Group type: EXPERIMENTAL
Intervention: F-scan pressure sensitive insole system
Number of subjects: 0
Study 8916520 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-managed smoking cessation program including a meeting with the nurse-case manager, videotape, workbook, relaxation audiotape, nicotine replacement therapy, and nurse-initiated phone contacts after discharge
Number of subjects: 660
Study 8916520 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 660
Study 2011802 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intervention
Number of subjects: 4087
Study 2011802 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity intervention
Number of subjects: 4087
Study 2011802 — intervention group
Group type: COMPARATOR
Intervention: Control area
Number of subjects: 4087
Study 7114339 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (family involvement and home visits)
Number of subjects: 218
Study 7114339 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (home visits from nurses and pharmacists)
Number of subjects: 218
Study 7114339 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 218
Study 31067282 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 video clips related to maternal and neonatal health information
Number of subjects: 155
Study 28859485 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyberwand
Number of subjects: 201
Study 28859485 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithoclast Select
Number of subjects: 201
Study 28859485 — intervention group
Group type: EXPERIMENTAL
Intervention: StoneBreaker
Number of subjects: 201
Study 28859485 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 201
Study 26363417 — intervention group
Group type: EXPERIMENTAL
Intervention: lipid emulsion alone (LE, Fabuless™ 4.2g lipid, 0.2MJ)
Number of subjects: 18
Study 26363417 — intervention group
Group type: COMPARATOR
Intervention: lipid control alone (LC, 4.2g lipid, 0.2 MJ)
Number of subjects: 18
Study 26363417 — intervention group
Group type: EXPERIMENTAL
Intervention: LE+yoghurt (1.2 MJ)
Number of subjects: 18
Study 26363417 — intervention group
Group type: COMPARATOR
Intervention: LC+yoghurt (1.2MJ)
Number of subjects: 18
Study 23351426 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse information on the risks of the combined oral pill
Number of subjects: 527
Study 23351426 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotional material on the vaginal ring and transdermal patch
Number of subjects: 527
Study 23351426 — intervention group
Group type: COMPARATOR
Intervention: Basic information on contraceptive products
Number of subjects: 527
Study 21401534 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (CBT) for 10 weeks
Number of subjects: 84
Study 21401534 — intervention group
Group type: COMPARATOR
Intervention: Control group (self-help material with e-mail contact)
Number of subjects: 84
Study 21401534 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (CBT)
Number of subjects: 84
Study 19642772 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow phonetic transcription of test consonants
Number of subjects: 50
Study 19642772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinal scale rating of resonance
Number of subjects: 50
Study 19642772 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived velopharyngeal closure (VPC)
Number of subjects: 50
Study 19642772 — intervention group
Group type: EXPERIMENTAL
Intervention: Velopharyngeal composite score (VPC-sum)
Number of subjects: 50
Study 16730732 — intervention group
Group type: EXPERIMENTAL
Intervention: THD 1g daily
Number of subjects: 25
Study 16730732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 16009786 — intervention group
Group type: COMPARATOR
Intervention: ACEIs
Number of subjects: 179122
Study 16009786 — intervention group
Group type: COMPARATOR
Intervention: CCBs
Number of subjects: 179122
Study 11936564 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole 200 mg q 12 h
Number of subjects: 24
Study 11936564 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole 300 mg q 12 h
Number of subjects: 24
Study 11936564 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 400 mg OD
Number of subjects: 24
Study 10327908 — intervention group
Group type: EXPERIMENTAL
Intervention: Reassurance (reiterated safety assurances)
Number of subjects: 53
Study 10327908 — intervention group
Group type: COMPARATOR
Intervention: Control dial (patients were instructed on using an operative dial to reduce the concentration of CO2 in the breathing canopy)
Number of subjects: 53
Study 10327908 — intervention group
Group type: COMPARATOR
Intervention: Basic instructions (standard information)
Number of subjects: 53
Study 7703619 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium absorption (net and true) measured in 18-day balances and by a two-isotope deconvolution method (fractional absorption and maximum absorption rate, MAR)
Number of subjects: 25
Study 1668825 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery with radiation
Number of subjects: 0
Study 1668825 — intervention group
Group type: COMPARATOR
Intervention: Breast-conserving surgery without radiation
Number of subjects: 0
Study 1668825 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation after mastectomy
Number of subjects: 0
Study 1668825 — intervention group
Group type: COMPARATOR
Intervention: Systemic adjuvant chemotherapy alone
Number of subjects: 0
Study 7073151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine, 300 mg four times daily for 1 day
Number of subjects: 6
Study 7073151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31362765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) - 1-g loading dose followed by 3-g maintenance dose over 24 hours
Number of subjects: 12000
Study 31362765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12000
Study 31362765 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 12000
Study 27038416 — intervention group
Group type: EXPERIMENTAL
Intervention: VL20 (20% velocity loss)
Number of subjects: 22
Study 27038416 — intervention group
Group type: COMPARATOR
Intervention: VL40 (40% velocity loss)
Number of subjects: 22
Study 26166678 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention offering $20 incentives for connecting to quitline
Number of subjects: 0
Study 26166678 — intervention group
Group type: COMPARATOR
Intervention: Perceived incentive importance
Number of subjects: 0
Study 24703047 — intervention group
Group type: EXPERIMENTAL
Intervention: Albiglutide 30 mg once weekly titrated to 50 mg at week 6
Number of subjects: 841
Study 24703047 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide 0.6 mg once daily titrated to 1.2 mg at week 1 and 1.8 mg at week 2
Number of subjects: 841
Study 24703047 — intervention group
Group type: EXPERIMENTAL
Intervention: Albiglutide
Number of subjects: 841
Study 24703047 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide
Number of subjects: 841
Study 22245322 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation therapy (placebo group)
Number of subjects: 516
Study 18951459 — intervention group
Group type: EXPERIMENTAL
Intervention: Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS) pre- and post-treatment
Number of subjects: 56
Study 18951459 — intervention group
Group type: EXPERIMENTAL
Intervention: Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS)
Number of subjects: 56
Study 18951459 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Disorder Examination scores
Number of subjects: 56
Study 18951459 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfectionism
Number of subjects: 56
Study 18951459 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulsivity
Number of subjects: 56
Study 18951459 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum lifetime BMI
Number of subjects: 56
Study 17472616 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B alone (n = 15)
Number of subjects: 17
Study 17472616 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B and 5-fluorocytosine (n = 3)
Number of subjects: 17
Study 17472616 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B and itraconazole (n = 2)
Number of subjects: 17
Study 17472616 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurosurgery (4 patients)
Number of subjects: 17
Study 15678733 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion 15 microg kg(‐1) h(‐1)
Number of subjects: 192
Study 15678733 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil infusion 60 microg kg(‐1) h(‐1)
Number of subjects: 192
Study 12080408 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-micronutrient supplementation (daily tablet containing 1000 microg vitamin A)
Number of subjects: 977
Study 12080408 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-helminth chemotherapy (single treatment with albendazole 600 mg and praziquantel 40 mg/kg)
Number of subjects: 977
Study 12080408 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in S. mansoni egg output
Number of subjects: 977
Study 10335041 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic bacteriuria (a.b.) in women with SLE
Number of subjects: 85
Study 10335041 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial colonisation of nostrils and pharynx in SLE patients with a.b.
Number of subjects: 85
Study 10335041 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical observation of patients with a.b.
Number of subjects: 85
Study 7807254 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional method of instruction
Number of subjects: 70
Study 7807254 — intervention group
Group type: COMPARATOR
Intervention: Computer method of instruction
Number of subjects: 70
Study 2762760 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with Hemoccult‐II
Number of subjects: 60938
Study 824884 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 24
Study 824884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 29931108 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-focused MNCH program
Number of subjects: 1000
Study 29931108 — intervention group
Group type: COMPARATOR
Intervention: Standard MNCH program
Number of subjects: 1000
Study 29931108 — intervention group
Group type: EXPERIMENTAL
Intervention: Husbands' behavioral determinants and support
Number of subjects: 1000
Study 26581683 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated green tea extract (GTE) 1315 mg total catechins/d
Number of subjects: 237
Study 26581683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study 26581683 — intervention group
Group type: EXPERIMENTAL
Intervention: COMT high-activity (G/G) genotype
Number of subjects: 237
Study 26581683 — intervention group
Group type: EXPERIMENTAL
Intervention: COMT low-activity (A/A) genotype
Number of subjects: 237
Study 24533491 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Dynamic Stretching (SDS)
Number of subjects: 37
Study 24533491 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Dynamic Stretching (ADS)
Number of subjects: 37